Lifevantage Corporation Common Stock (Delaware) LFVN
$5.22
+3.37%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (1 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $8.50
- Implied Upside
- +62.8%
- Price Target Range
- $6.00 – $11.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-28 | Lake StreetRyan Meyers |
Maintains | Hold | $5 → $6 |
| 2026-05-07 | Lake StreetBrooks O'Neil |
Downgrades | Buy → Hold | $5 |
| 2026-02-18 | Freedom BrokerIlya Zubkov |
Maintains | Buy | $17 → $11 |
| 2025-01-14 | Craig-HallumAlex Fuhrman |
Initiates coverage on | Buy | $35 |
| 2024-12-19 | Lake StreetBrooks O'Neil |
Initiates coverage on | Buy | $26 |
| 2014-02-12 | Imperial Capital |
Initiates coverage on | In-line | $15 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.22
- Market Cap
- $65.72 million
- 52-Week Range
- $3.90 – $11.71
- Average Volume
- 27K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.